SpyGlass Pharma, Inc. Common Stock

NASDAQ:SGP

Biotechnology

Healthcare
$29.68 +2.49%

+$0.45 today

Market cap
$993.14M
Beta
-0.34
P/E (TTM)
-14.1
EPS (TTM)
-$1.32
52W Low $17.06High $32.44

Volume 0.10M

Average 0.09M

Returns on capital

SpyGlass Pharma, Inc. Common Stock management

Start with the returns management earns on the capital it controls, then review the people, their trades, and growth quality.

Return Metrics

ROE, ROIC & ROA over time

Management

ROE

40.3%

avg 40.3%

ROIC

-38.6%

avg -38.6%

ROA

-34.4%

avg -34.4%

Analysis

ROE is currently the strongest return metric at 40.3% versus its period average of 40.3%. 1 of 3 return metrics are above their quality threshold, which helps indicate how efficiently the company turns capital and assets into profit.

Leadership

Who runs the company?

Review the executive team, tenure, compensation, and ownership.

Management

Key executives, compensation & ownership

NameTitleCompensationAgeShares OwnedOwnership %

Patrick H. Mooney

CEO & DirectorUSD 659.63K52——

Chetan Pujara

Chief Research & Development OfficerUSD 523.39K56——

Malik Y. Kahook

Co-Founder, President, Chief Medical Officer & Executive ChairmanUSD 424.23K51——

Mike Pinder

Vice President of Marketing————

Rachel Gilette

Vice President of Human Resources————

Shannon Trevino

General Counsel————

Glenn Sussman

Co-founder & Chief Technology Advisor—62——

James Robert Dennewill Jr.

Chief Operating Officer—45——

Jean-Frederic Viret

Chief Financial Officer—60——

Paul Yoo

Senior Vice President of Clinical Development————

Compensation is shown in the reported currency; data updated Nov 7, 2026.

Ownership uses each executive's latest SEC Form 4 holding only when the full name maps to one reporting CIK.

Insider trading

Are insiders buying or selling?

Follow recent insider purchases and sales reported on Form 4.

Insider Trading

SEC Form 4 transactions — last 12 months

No open-market purchases or sales in the last 12 months.

Growth analysis

Is management growing the business?

Compare historical growth with analyst forecasts across revenue, earnings, and cash flow.

Growth Analysis

Historical CAGR & forward analyst estimates

Metric 10yr 5yr3yr Fwd Est.
EPSN/AN/AN/A
N/A1 analysts
RevenueN/AN/AN/A
N/A3 analysts
Net IncomeN/AN/AN/A
N/A3 analysts
EBITN/AN/AN/A
N/A3 analysts

Analysis

Analysis will appear once historical growth or forward estimates are available for this company.

Competitors

Who does SpyGlass Pharma, Inc. Common Stock compete with?

Open similar companies to compare how their management teams allocate capital.

Questions

Management questions

Common questions about SGP's management, answered from reported figures.

Who manages SGP?

SpyGlass Pharma, Inc. Common Stock (SGP) lists 10 active executives. The top listed executive is Chetan Pujara, Chief Research & Development Officer.